In this study, we used electronic patient-reported outcomes (ePRO) through a remote symptom monitoring program in MM patients experiencing variable levels of pain.
CareviveMay 18, 2023
The aim of this study was to determine feasibility of patients using a touchscreen computer to record goals, preferences and top concerns to share with the physician at a treatment decision visit.
CareviveDecember 12, 2022
Acute myeloid leukemia (AML) by numbers. In this infographic, we'd like to highlight some important facts and figures on AML as well as key learnings from Carevive SMART Data™.
CareviveMay 27, 2022
This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.
CareviveDecember 15, 2021
Patient responses to weekly electronic patient reported outcomes using the Carevive PROmpt® platform
This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.
CareviveOctober 12, 2021
This project represents the first assessment of Oral Medication (OM) adherence in patients with AML.
CareviveMay 14, 2020
Authors: Ashley Leak Bryant PhD, RN1 ; Ya-Ning Chan RN, MSN1 ; Jaime Richardson RN, BSN1; Matthew Foster, MD1 ; Debra Wujcik, PhD, RN2 1 The University of North Carolina at Chapel Hill School of Nursing; 2 North Carolina Cancer Hospital, Lineberger Comprehensive Cancer Center, Division of Hematology and Oncology, The University of North Carolina at Chapel Hill 3 Carevive…
CareviveMay 5, 2020
Note: This on-demand video is not available for CME/CNE credit. Acute myeloid leukemia (AML) is a disease of older adults, with a median age of presentation of 67 years; only 5-10% of patients are alive at 5 years. Traditionally older patients have not received intensive induction chemotherapy to avoid toxicities, yet current research shows fit patients treated with intensive chemotherapy…
CareviveJuly 25, 2018
